Biotech · Private company
Inflammasome Therapeutics
Track this companyFree. Adds Inflammasome Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- K8Phase 2 · Geographic AtrophyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Evaluation of K9 in Subjects With Diabetic Macular Edema (DME)PHASE1 · TERMINATED · started Mar 13, 2025ClinicalTrials.gov NCT06781255 · fetched Nov 12, 2026
- Evaluation of K9 in Subjects With Thyroid Eye Disease (TED)PHASE1 · TERMINATED · started Nov 6, 2024ClinicalTrials.gov NCT06467435 · fetched Nov 12, 2026
- Evaluation of Kamuvudine-8 in Subjects With Geographic AtrophyPHASE1_PHASE2 · COMPLETED · started Apr 18, 2024ClinicalTrials.gov NCT06164587 · fetched Nov 12, 2026
- Safety and Effect of Intravitreal Injection of a Derivative of Nucleoside Reverse Transcriptase Inhibitor in Subjects with Diabetic Macular EdemaPHASE1 · COMPLETED · started Jan 4, 2024ClinicalTrials.gov NCT05699759 · fetched Nov 12, 2026